Sartorius Stedim Biotech S.A.

ENXTPA-DIM

Overview Financials Investor Relations Estimates Ownership Industry Dividends Modeling Filings

Income Statement	Dec '14	Dec '15	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	LTM
Total Revenues						1,440.6	1,910.1	2,887	3,492.7	2,775.5	2,746.9
Total Revenues % Chg.						18.8%	32.6%	51.1%	21%	-20.5%	-13.4%
Cost of Goods Sold, Total						692.3	906.8	1,334	1,675.4	1,542	1,561.4
Gross Profit						748.3	1,003.3	1,553	1,817.3	1,233.5	1,185.5
Selling General & Admin Expenses, Total						317.6	391.8	531.9	612.3	617.8	636.2
R&D Expenses						79.2	84.5	110.5	132.4	129.5	134.2
Other Operating Expenses						3.5	23.9	-9.6	18.2	17.5	-1.8
Other Operating Expenses, Total						400.4	500.2	632.8	762.9	764.8	768.6
Operating Income						347.9	503.1	920.2	1,054.4	468.7	416.9
Interest Expense, Total						-3.9	-6.5	-10.2	-18.2	-115.4	-168.6
Interest And Investment Income						0.3	0.5	0.3	0.5	6.2	10.8
Net Interest Expenses						-3.5	-6	-9.9	-17.7	-109.2	-157.8
Currency Exchange Gains (Loss)						-11.7	-14.7	12.3	-32.8	-18.6	-18.6
Other Non Operating Income (Expenses)						1.5	1.1	-37.1	-4.6	0.6	0.7
EBT, Excl. Unusual Items						334.2	483.6	885.5	999.3	341.5	241.2
Restructuring Charges	—		—	—	—	—	—	—	—	—	—
Merger & Related Restructuring Charges	—		—	—	—	-0.3	-4.3	-20.3	—	—	—
Other Unusual Items		—				-16.5	-18.6	-218.5	131.1	59.6	-4.8
EBT, Incl. Unusual Items						317.4	460.7	646.7	1,130.4	401.1	236.4
Income Tax Expense						81.4	122.1	232.4	250.5	89	63
Earnings From Continuing Operations						236	338.6	414.3	879.9	312.1	173.4
Minority Interest						-1.5	-2.7	0.1	-3.8	-2.4	-3.9
Net Income						234.5	335.9	414.4	876.1	309.7	169.5
Net Income to Common Incl Extra Items						234.5	335.9	414.4	876.1	309.7	169.5
Net Income to Common Excl. Extra Items						234.5	335.9	414.4	876.1	309.7	169.5
Total Shares Outstanding						92.2	92.2	92.2	92.2	92.2	95.2
Weighted Avg. Shares Outstanding						92.2	92.2	92.2	92.2	92.2	94.2
Weighted Avg. Shares Outstanding Dil						92.2	92.2	92.2	92.2	92.2	94.2
EPS						2.5	3.6	4.5	9.5	3.4	1.8
EPS Diluted						2.5	3.6	4.5	9.5	3.4	1.8
EBITDA						401.5	577.3	1,031.4	1,196.9	657.8	651.9
Effective Tax Rate						25.6%	26.5%	35.9%	22.2%	22.2%	26.6%